Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Endocyte
4200
Endocyte
Health Care
Technology
Biotechnology
Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.
Suggest edits
Founded
1996
Raised
$71M
Follow us
Companies in the same industry
ELPIS BIOMED LTD
Finch Therapeutics Group
Prevail Therapeutics
APRINOIA Therapeutics
AptaCam
Erasca
SANSURE
EarlySense
miRdetect
Medigus
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$15,000,000
Venture capital - 2010
$26,000,000
Venture capital (Series C) - 2010
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
Xconomy
Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal
Health
Xconomy
Endocyte Cuts Workforce by 40 Percent After Clinical Trial Falters
Health
Strategy
